Wikidata

(Q64150331)

English

A Study to Evaluate the Safety and Efficacy of Ustekinumab Induction and Maintenance Therapy in Participants With Moderately to Severely Active Ulcerative Colitis

clinical trial

In more languages

Statements

short name
UNIFI (English)
0 references
title
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Protocol to Evaluate the Safety and Efficacy of Ustekinumab Induction and Maintenance Therapy in Subjects With Moderately to Severely Active Ulcerative Colitis (English)
0 references
medical condition
colitis
0 references
country
Australia
0 references
Austria
0 references
Belgium
0 references
Bulgaria
0 references
Canada
0 references
Denmark
0 references
France
0 references
Germany
0 references
Hungary
0 references
Israel
0 references
Japan
0 references
Netherlands
0 references
New Zealand
0 references
Poland
0 references
Romania
0 references
Serbia
0 references
Slovakia
0 references
Ukraine
0 references
United Kingdom
0 references
start time
10 July 2015
0 references
end time
10 August 2018
0 references
number of participants
972
0 references
minimum age
18 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q64150331&oldid=1857570176"